Results 1 to 10 of about 7,355 (191)

Epilepsy in adult patients with tuberous sclerosis complex. [PDF]

open access: yesActa Neurol Scand, 2021
Abstract Objectives Little is known about the evolution of epilepsy in individuals with tuberous sclerosis complex (TSC) in adulthood. This study aims at describing the characteristics of epilepsy in adult TSC patients attending a single multidisciplinary clinic.
Vignoli A   +9 more
europepmc   +2 more sources

Schizofrenia: Study of Tendency and Distribution [PDF]

open access: yesEuropean Psychiatry, 2022
Introduction The prevalence of schizophrenia is close to 1 percent internationally. According to the 2019 census, the population in the province of León, our study population, is 460,001 inhabitants. Objectives To study the distribution of schizofrenia
C. Vilella Martín   +6 more
doaj   +2 more sources

Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta-analysis. [PDF]

open access: yesHum Psychopharmacol, 2021
Abstract Background Depressive symptoms occur in several psychiatric disorders, often in the absence of a formal diagnosis of depression. We aimed to evaluate the efficacy and the tolerability of amisulpride, both alone and as augmentation therapy, in the treatment of depressive symptoms in individuals with any major psychiatric disorder.
Zangani C   +5 more
europepmc   +2 more sources

Social cognition and emotional rehabilitation in participants with schizofrenia [PDF]

open access: yesFrontiers in Psychiatry, 2023
IntroductionPeople with schizophrenia have deficits in social cognition, emotion and social perception, as well as attributional style. The purpose of this study was to evaluate the efficacy of a multicomponent social cognition training program, e ...
Francisco Rodríguez Pulido   +8 more
doaj   +2 more sources

Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine. [PDF]

open access: yesWiley Interdiscip Rev Nanomed Nanobiotechnol
A comprehensive overview of the key characteristics of nanoparticles aimed at targeting various brain regions and specific neuronal cells is provided. Recent advancements in nanoparticles custom‐made for different brain conditions, ranging from neurodegenerative disorders to brain tumors, are emphasized. The review offers recommendations and identifies
Sierri G   +13 more
europepmc   +2 more sources

Jakość życia pacjentów ze schizofrenią

open access: yesInnowacje w Pielęgniarstwie i Naukach o Zdrowiu, 2021
Wstęp. Schizofrenia jest chorobą psychiczną, którą charakteryzuje zróżnicowany obraz i przebieg kliniczny, charakteryzuje się przede wszystkim zakłóceniami myślenia i postrzegania, a także niedostosowanym i spłyconym afektem.
Agnieszka Okroj
doaj   +1 more source

Urojeniowy typ schizofazji. Na przykładzie analizy tekstów schizofatycznych

open access: yesLogopaedica Lodziensia, 2023
Schizofazję zwykle kojarzy się z niespójnością wypowiedzi w jej wymiarach semantycznym i formalno‑gramatycznym. Artykuł podnosi kwestię niespójności pragmatycznej tekstu i zawiera propozycje włączenia do spektrum schizofazji także wypowiedzi odnoszących ...
Tomasz Woźniak
doaj   +1 more source

Il ruolo della costruzione di scenari nella spiegazione dei disturbi macrolinguistici della schizofrenia

open access: yesRivista Internazionale di Filosofia e Psicologia, 2021
Al centro di questo articolo è l’analisi dei fondamenti neurocognitivi dei deficit macrolinguistici, discorsivo-narrativi nello specifico, osservabili nei pazienti affetti da schizofrenia. Tale analisi è condotta in riferimento alle ricerche svolte negli
Elio Carlo   +2 more
doaj   +1 more source

Mario Mieli filosofo queer-freudiano

open access: yesBalthazar, 2022
In questo paper si intende inquadrare i rapporti dell’attivista italiano Mario Mieli con la psicoanalisi, per definirlo come “filosofo queer-freudiano”, nonché raffinato e innovativo interprete del testo di Freud: a questo fine, bisogna innanzitutto ...
Sara Fontanelli
doaj   +1 more source

Retrospective analysis of hospitalization rates in patients with schizophrenia 12 months before and 12 months after the switch on once-monthly long-acting injectable paliperidone palmitate [PDF]

open access: yesVojnosanitetski Pregled, 2023
Background/Aim. There is no available published data about the use of long-acting injectable paliperidone palmitate (PP) in schizophrenia patients in the Republic of Serbia.
Totić-Poznanović Sanja   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy